This paper discusses the relationship between medical innovations and ageing from a health economics perspective and surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health innovations. Particular focus is on the endogeneity of...

This paper studies the impact of the first effective medical treatment for an infectious disease -diphtheria antitoxin- on the historical health transition in the United States. Using an instrumental variable for local antitoxin adoption rates and information from approximately 1.6 million death...

Innovative products form the foundation for the international success of electromedical technology in Germany. This is shown both in the strong sales achieved by the German medical technology segment compared with other industrial countries and the export share of more than 70%, which even...

The allocation and rationing of health care resources is, no doubt, one of the most pressing issues confronting contemporary society. These issues¿considered from a micro and a macro level of economic analysis¿are linked inextricably to utilitarianism which, in turn, relies upon a cost-benefit...